InsiderClue
Insiders · Profile

Violin Jonathan

Chief Executive Officer at Viridian Therapeutics, Inc.\DE. Filing since 1 Feb 2022. CIK 0001730615

Company
Date
Role
Action
Shares
Amount
Of holding
VRDN Viridian Therapeutics, Inc.\DE
2 Feb 2023
Chief Executive Officer
Sold, plan not stated
50,000
$1.84M
10.4%
VRDN Viridian Therapeutics, Inc.\DE
1 Jun 2022
Chief Executive Officer
Sold, plan not stated
30,000
$366.00K
5.9%
VRDN Viridian Therapeutics, Inc.\DE
2 May 2022
Chief Executive Officer
Sold, plan not stated
30,000
$391.20K
5.5%
VRDN Viridian Therapeutics, Inc.\DE
4 Apr 2022
Chief Executive Officer
Sold, plan not stated
3,600
$68.15K
0.7%
VRDN Viridian Therapeutics, Inc.\DE
1 Apr 2022
Chief Executive Officer
Sold, plan not stated
26,400
$499.49K
4.6%
VRDN Viridian Therapeutics, Inc.\DE
2 Mar 2022
Chief Executive Officer
Sold, plan not stated
11,106
$192.80K
1.9%
VRDN Viridian Therapeutics, Inc.\DE
1 Mar 2022
Chief Executive Officer
Sold, plan not stated
18,894
$336.69K
3.1%
VRDN Viridian Therapeutics, Inc.\DE
3 Feb 2022
Chief Executive Officer
Sold, plan not stated
909
$17.42K
0.2%
VRDN Viridian Therapeutics, Inc.\DE
2 Feb 2022
Chief Executive Officer
Sold, plan not stated
12,340
$227.92K
2.0%
VRDN Viridian Therapeutics, Inc.\DE
1 Feb 2022
Chief Executive Officer
Sold, plan not stated
16,751
$327.48K
2.7%
10 decisions on file.